BSX - BOSTON SCIENTIFIC CORP
104.49
-0.050 -0.048%
Share volume: 5,460,182
Last Updated: Fri 21 Feb 2025 10:00:00 PM CET
Surgical and Medical Instrument Manufacturing :
-0.23%
PREVIOUS CLOSE
CHG
CHG%
$104.54
-0.87
-0.01%
View ratios
| Fiscal Date | 2023-12-31 | 2023-12-31 | 2024-03-31 | 2024-03-31 | 2024-06-30 | 2024-06-30 | 2024-09-30 | 2024-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2024-11-01 | 2024-02-20 | 2024-05-01 | 2024-05-01 | 2024-08-01 | 2024-08-01 | 2024-11-01 | 2025-02-18 | |
| Assets | |||||||||
| Total Assets | 35.136 B | 35.134 B | 36.669 B | 36.669 B | 37.108 B | 37.110 B | 38.078 B | 39.395 B | |
| Current Assets | 6.514 B | 6.513 B | 8.185 B | 8.184 B | 8.991 B | 8.992 B | 8.761 B | 6.920 B | |
| Inventories | 2.484 B | 2.484 B | 2.561 B | 2.561 B | 2.608 B | 2.608 B | 2.753 B | 2.810 B | |
| Other Current Assets | 0.000 | 806.000 M | 0.000 | 897.000 M | 0.000 | 996.000 M | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 806.000 M | 0.000 | 897.000 M | 0.000 | 996.000 M | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 2.228 B | 0.000 | 2.304 B | 0.000 | 2.400 B | 0.000 | 0.000 | |
| Current Cash | 865.000 M | 865.000 M | 2.329 B | 2.329 B | 2.913 B | 2.913 B | 2.502 B | 414.000 M | |
| Total Non-current Assets | 0.000 | 28.621 B | 0.000 | 28.485 B | 0.000 | 28.118 B | 0.000 | 0.000 | |
| Property Plant Equipment | 2.859 B | 2.859 B | 2.897 B | 2.897 B | 2.951 B | 2.951 B | 3.072 B | 3.294 B | |
| Other Assets | 25.762 B | 619.000 M | 25.588 B | 663.000 M | 25.166 B | 612.000 M | 26.245 B | 29.182 B | |
| Intangible Assets | 0.000 | 6.003 B | 0.000 | 5.839 B | 0.000 | 5.417 B | 0.000 | 0.000 | |
| Goodwill | 0.000 | 14.387 B | 0.000 | 14.361 B | 0.000 | 14.397 B | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 35.136 B | 35.134 B | 36.669 B | 36.669 B | 37.108 B | 37.110 B | 38.078 B | 39.395 B | |
| Total liabilities | 15.605 B | 15.853 B | 16.501 B | 16.743 B | 16.499 B | 16.736 B | 17.122 B | 17.392 B | |
| Total current liabilities | 4.933 B | 4.932 B | 4.916 B | 4.917 B | 5.576 B | 5.576 B | 5.910 B | 6.399 B | |
| Accounts Payable | 942.000 M | 942.000 M | 921.000 M | 921.000 M | 906.000 M | 906.000 M | 907.000 M | 960.000 M | |
| Other liabilities | 1.967 B | 1.578 B | 1.919 B | 1.536 B | 1.800 B | 1.434 B | 1.841 B | 1.870 B | |
| Current long term debt | 0.000 | 531.000 M | 0.000 | 1.085 B | 0.000 | 1.580 B | 0.000 | 0.000 | |
| Long term debt | 8.571 B | 8.571 B | 9.534 B | 9.534 B | 8.991 B | 8.991 B | 9.233 B | 8.968 B | |
| Other liabilities | 1.967 B | 1.578 B | 1.919 B | 1.536 B | 1.800 B | 1.434 B | 1.841 B | 1.870 B | |
| Minority interest | 0.000 | 248.000 M | 0.000 | 242.000 M | 0.000 | 238.000 M | 0.000 | 0.000 | |
| Total Shareholder equity | 19.281 B | 19.281 B | 19.925 B | 19.925 B | 20.372 B | 20.372 B | 20.708 B | 21.770 B | |
| Common stock | 20.664 B | 1.466 B | 20.730 B | 1.468 B | 20.820 B | 1.471 B | 20.980 B | 21.073 B | |
| Retained earnings | 819.000 M | 819.000 M | 1.314 B | 1.314 B | 1.639 B | 1.639 B | 2.107 B | 2.673 B |